GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novavax Inc (MEX:NVAX) » Definitions » E10

Novavax (MEX:NVAX) E10 : MXN-264.36 (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Novavax E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Novavax's adjusted earnings per share data for the three months ended in Dec. 2024 was MXN-10.636. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN-264.36 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Novavax was 11.20% per year. The lowest was -12.00% per year. And the median was -0.65% per year.

As of today (2025-03-04), Novavax's current stock price is MXN162.50. Novavax's E10 for the quarter that ended in Dec. 2024 was MXN-264.36. Novavax's Shiller PE Ratio of today is .


Novavax E10 Historical Data

The historical data trend for Novavax's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novavax E10 Chart

Novavax Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -190.13 -249.60 -257.00 -227.27 -264.36

Novavax Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -227.27 -228.08 -241.30 -261.22 -264.36

Competitive Comparison of Novavax's E10

For the Biotechnology subindustry, Novavax's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novavax's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novavax's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novavax's Shiller PE Ratio falls into.



Novavax E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novavax's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-10.636/133.1571*133.1571
=-10.636

Current CPI (Dec. 2024) = 133.1571.

Novavax Quarterly Data

per share eps CPI Adj_EPS
201503 -30.490 99.621 -40.754
201506 -25.104 100.684 -33.201
201509 -40.555 100.392 -53.791
201512 -99.731 99.792 -133.075
201603 -99.841 100.470 -132.323
201606 -107.262 101.688 -140.456
201609 -92.810 101.861 -121.325
201612 -86.591 101.863 -113.194
201703 -60.253 102.862 -77.999
201706 -57.843 103.349 -74.526
201709 -54.618 104.136 -69.839
201712 -62.846 104.011 -80.457
201803 -50.869 105.290 -64.333
201806 -46.569 106.317 -58.326
201809 -43.583 106.507 -54.488
201812 -51.051 105.998 -64.131
201903 -40.930 107.251 -50.817
201906 -32.463 108.070 -39.999
201909 -14.609 108.329 -17.957
201912 -21.312 108.420 -26.175
202003 -13.600 108.902 -16.629
202006 -6.925 108.767 -8.478
202009 -70.912 109.815 -85.985
202012 -53.708 109.897 -65.076
202103 -62.345 111.754 -74.285
202106 -94.554 114.631 -109.835
202109 -88.622 115.734 -101.963
202112 -229.347 117.630 -259.622
202203 50.972 121.301 55.954
202206 -131.371 125.017 -139.925
202209 -43.247 125.227 -45.986
202212 -44.451 125.222 -47.268
202303 -61.465 127.348 -64.269
202306 9.943 128.729 10.285
202309 -21.948 129.860 -22.505
202312 -24.952 129.419 -25.673
202403 -17.426 131.776 -17.609
202406 18.137 132.554 18.220
202409 -14.965 133.029 -14.979
202412 -10.636 133.157 -10.636

Add all the adjusted EPS together and divide 10 will get our e10.


Novavax  (MEX:NVAX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Novavax E10 Related Terms

Thank you for viewing the detailed overview of Novavax's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Novavax Business Description

Traded in Other Exchanges
Address
700 Quince Orchard Road, Gaithersburg, MD, USA, 20878
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.